Kim Novak, the iconic star of Alfred Hitchcock’s “Vertigo,” has publicly expressed her disapproval of Miramax’s upcoming biopic, “Scandalous,” specifically objecting to Sydney Sweeney’s casting as herself. Novak, 90, told The Times of London she “would have never approved” the film, citing concerns about the portrayal of her relationship with Sammy Davis Jr. And Sweeney’s overall image. This clash highlights a growing tension between legacy stars asserting control over their narratives and studios capitalizing on recognizable names for contemporary audiences.
The Weight of Vertigo: Why Novak’s Disapproval Matters Now
This isn’t simply a case of a star quibbling over casting. Novak’s protest arrives at a particularly sensitive moment for Miramax, and for Hollywood’s broader strategy of revisiting classic stories. The studio, resurrected after a turbulent period under various ownerships, is clearly aiming for prestige and awards attention with “Scandalous.” A public rebuke from the subject of the film throws a wrench into those plans. More broadly, it speaks to a larger conversation about authenticity, representation, and the ethics of biographical storytelling. The industry is increasingly grappling with how to honor the legacies of screen legends although simultaneously attracting a modern viewership. The timing is similarly crucial, dropping this weekend as awards season buzz for next year begins to build.
The Bottom Line
- Legacy Control: Kim Novak’s protest underscores the increasing desire of classic Hollywood figures to control their own narratives.
- Miramax Risk: The public disapproval poses a marketing challenge for Miramax, potentially impacting the film’s critical reception and box office performance.
- Biopic Backlash: This incident adds fuel to the debate surrounding the ethics of biographical films and the responsibility studios have to accurately and respectfully portray real-life figures.
Beyond the Waistline: The Core of Novak’s Concerns
Novak’s critique extends beyond Sweeney’s physical appearance – her comment about Sweeney “sticking out so much above the waist” has understandably drawn attention, but it’s the deeper concerns about the film’s focus that are more telling. Novak insists her relationship with Davis was rooted in shared intellectual and artistic interests, not merely sexual attraction. She fears “Scandalous” will sensationalize their connection, reducing it to a scandalous affair. This fear isn’t unfounded. Hollywood has a long history of prioritizing drama over nuance, particularly when dealing with interracial relationships and the complexities of the mid-20th century. The original story, as reported in late 2024, already hinted at the potential for a heavily dramatized narrative.
The Miramax Play: A Calculated Risk in a Shifting Landscape
Miramax, under its current leadership, is attempting a delicate balancing act. The studio is betting on Colman Domingo’s directorial vision – he’s a critically acclaimed filmmaker known for his sensitive and nuanced work – to deliver a compelling and respectful portrayal of Novak and Davis. However, the choice of Sweeney, a rising star known for her provocative roles in projects like “Euphoria” and “Anyone But You,” feels strategically calculated to draw a younger audience. This represents a common tactic in Hollywood: casting bankable, contemporary stars to boost a project’s visibility. But it’s a gamble, especially when dealing with a subject as sensitive as this. Variety reported extensively on Miramax’s restructuring and its focus on acquiring and developing high-profile projects. The studio is clearly aiming to re-establish itself as a major player in the independent film space.
The Streaming Factor: How Biopics Navigate the New Distribution Models
The release strategy for “Scandalous” will be crucial. While a theatrical run is likely, the film’s ultimate success will depend on its performance on streaming platforms. Miramax will need to weigh the potential for box office revenue against the broader reach and subscriber acquisition benefits of a streaming deal. The current streaming landscape is fiercely competitive, with Netflix, Disney+, and Amazon Prime Video all vying for dominance. The Hollywood Reporter has detailed the ongoing “streaming wars” and the challenges studios face in navigating this fragmented market. Biopics, particularly those with strong star power, often perform well on streaming, but they also need to generate enough buzz to cut through the noise.
The Davis Jr. Estate: A Parallel Narrative
It’s worth noting the silence from the Sammy Davis Jr. Estate. While Novak is voicing her concerns, the estate’s perspective on the film’s portrayal of Davis is equally important. Davis Jr. Faced immense racism throughout his career, and any misrepresentation of his experiences could be deeply damaging. The estate has been actively involved in preserving Davis’s legacy, including the recent restoration of his films and the release of previously unreleased recordings. Their approval, or lack thereof, could significantly impact the film’s reception.
Industry Voices on the Biopic Boom and Bust
“We’re seeing a saturation point with biopics. Audiences are becoming more discerning and demanding more than just a surface-level retelling of a famous life. They want insight, nuance, and a willingness to grapple with the complexities of the subject.” – Dr. Annette Hill, Professor of Film Studies at the University of Southern California, speaking to IndieWire in December 2023.
Hollywood’s Accountability Equation: A Data Snapshot
| Film | Year | Production Budget | Worldwide Box Office | Rotten Tomatoes Score |
|---|---|---|---|---|
| Bohemian Rhapsody | 2018 | $52 Million | $911 Million | 60% |
| Rocketman | 2019 | $40 Million | $302 Million | 79% |
| Elvis | 2022 | $85 Million | $286 Million | 77% |
| Oppenheimer | 2023 | $100 Million | $952 Million | 93% |
This table illustrates the financial risks and rewards associated with biopics. While some, like “Bohemian Rhapsody” and “Oppenheimer,” have been massive commercial successes, others have struggled to recoup their investment. Critical reception also plays a significant role, as evidenced by the varying Rotten Tomatoes scores.
The Novak situation is a stark reminder that Hollywood’s fascination with real-life stories comes with a responsibility to treat those stories – and the people they’re about – with respect. The industry is learning, often the hard way, that simply having a recognizable name attached to a project isn’t enough. Authenticity, sensitivity, and a willingness to engage with the complexities of the past are essential. The success of “Scandalous” will hinge not only on Domingo’s directorial skill and Sweeney’s performance, but also on Miramax’s ability to navigate this delicate situation and address Novak’s legitimate concerns. What are your thoughts? Do you think studios should have more control over the narratives of their subjects, or should artistic license always prevail? Let’s discuss in the comments below.
